Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia

Abstract Inflammatory abnormalities have been shown in the pathogenesis of schizophrenia. Soluble urokinase-type plasminogen activator receptor (suPAR) is a protein that is measurable in the circulating blood and reflects the inflammation in the body. We aimed to investigate serum suPAR levels in pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychiatry research 2016-02, Vol.236, p.179-181
Hauptverfasser: Genc, Abdullah, Kalelioglu, Tevfik, Karamustafalioglu, Nesrin, Tasdemir, Akif, Genc, Esra Sena, Akkus, Mustafa, Emul, Murat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 181
container_issue
container_start_page 179
container_title Psychiatry research
container_volume 236
creator Genc, Abdullah
Kalelioglu, Tevfik
Karamustafalioglu, Nesrin
Tasdemir, Akif
Genc, Esra Sena
Akkus, Mustafa
Emul, Murat
description Abstract Inflammatory abnormalities have been shown in the pathogenesis of schizophrenia. Soluble urokinase-type plasminogen activator receptor (suPAR) is a protein that is measurable in the circulating blood and reflects the inflammation in the body. We aimed to investigate serum suPAR levels in patients with schizophrenia who were in acute state and to compare with healthy controls. Forty five patients and 43 healthy controls were included in the study. We found no significant difference in suPAR levels between patients and controls, suggesting that suPAR as an inflammatory marker does not have a role in the inflammatory process of acute schizophrenia.
doi_str_mv 10.1016/j.psychres.2016.01.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1764138945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0165178115301062</els_id><sourcerecordid>1764138945</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-e95db7419c424874f10e9b74a19957ed95c492e734538a0f0301f6702359775a3</originalsourceid><addsrcrecordid>eNqFkU2PFCEQhonRuOPoX9hw9NKzQH_QXIxmo67JJh5Wz4Rhqh1maWiBHh3jj7c6s-vBi0klUFS9VcVThFxytuGMd1eHzZRPdp8gbwT6G8bR-idkxXspKslF_ZSsMNBWXPb8grzI-cAYE1yp5-RCdFI2vFcr8vsO0jzSHP289UDnFO9dMBmqcpqATt7k0YX4DQI1trijKTHRBBam5eLhCD5TF-hoUDyZ4iCUTH-4ssf8uQCFn8ZC2mIkBhoHmu3e_YoTDh6ceUmeDcZnePVwrsnXD--_XN9Ut58_frp-d1vZRtSlAtXutjivQrfpZTNwBgofDH6mlbBTrW2UAFk3bd0bNrCa8aGTTNStkrI19Zq8PtedUvw-Qy56dNmC9yZAnLPmsmt43SvUr0l3TrUp5pxg0FNyo0knzZleyOuDfiSvF_KacbQehZcPPebtCLu_skfUmPD2nIDI4Ogg6WwRl4WdQ6BF76L7f483_5Sw3gVnjb-HE-RDnFNAjprrLDTTd8v-l_XzFomwTtR_AG-4r1w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1764138945</pqid></control><display><type>article</type><title>Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Genc, Abdullah ; Kalelioglu, Tevfik ; Karamustafalioglu, Nesrin ; Tasdemir, Akif ; Genc, Esra Sena ; Akkus, Mustafa ; Emul, Murat</creator><creatorcontrib>Genc, Abdullah ; Kalelioglu, Tevfik ; Karamustafalioglu, Nesrin ; Tasdemir, Akif ; Genc, Esra Sena ; Akkus, Mustafa ; Emul, Murat</creatorcontrib><description>Abstract Inflammatory abnormalities have been shown in the pathogenesis of schizophrenia. Soluble urokinase-type plasminogen activator receptor (suPAR) is a protein that is measurable in the circulating blood and reflects the inflammation in the body. We aimed to investigate serum suPAR levels in patients with schizophrenia who were in acute state and to compare with healthy controls. Forty five patients and 43 healthy controls were included in the study. We found no significant difference in suPAR levels between patients and controls, suggesting that suPAR as an inflammatory marker does not have a role in the inflammatory process of acute schizophrenia.</description><identifier>ISSN: 0165-1781</identifier><identifier>EISSN: 1872-7123</identifier><identifier>DOI: 10.1016/j.psychres.2016.01.018</identifier><identifier>PMID: 26774189</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adult ; Biomarkers - blood ; Case-Control Studies ; Disease Progression ; Humans ; Inflammation ; Inflammation - blood ; Male ; Psychiatry ; Receptors, Urokinase Plasminogen Activator - blood ; Schizophrenia ; Schizophrenia - blood ; Schizophrenia - pathology ; Soluble urokinase-type plasminogen activator receptor</subject><ispartof>Psychiatry research, 2016-02, Vol.236, p.179-181</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2016 Elsevier Ireland Ltd</rights><rights>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-e95db7419c424874f10e9b74a19957ed95c492e734538a0f0301f6702359775a3</citedby><cites>FETCH-LOGICAL-c423t-e95db7419c424874f10e9b74a19957ed95c492e734538a0f0301f6702359775a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.psychres.2016.01.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26774189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Genc, Abdullah</creatorcontrib><creatorcontrib>Kalelioglu, Tevfik</creatorcontrib><creatorcontrib>Karamustafalioglu, Nesrin</creatorcontrib><creatorcontrib>Tasdemir, Akif</creatorcontrib><creatorcontrib>Genc, Esra Sena</creatorcontrib><creatorcontrib>Akkus, Mustafa</creatorcontrib><creatorcontrib>Emul, Murat</creatorcontrib><title>Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia</title><title>Psychiatry research</title><addtitle>Psychiatry Res</addtitle><description>Abstract Inflammatory abnormalities have been shown in the pathogenesis of schizophrenia. Soluble urokinase-type plasminogen activator receptor (suPAR) is a protein that is measurable in the circulating blood and reflects the inflammation in the body. We aimed to investigate serum suPAR levels in patients with schizophrenia who were in acute state and to compare with healthy controls. Forty five patients and 43 healthy controls were included in the study. We found no significant difference in suPAR levels between patients and controls, suggesting that suPAR as an inflammatory marker does not have a role in the inflammatory process of acute schizophrenia.</description><subject>Adult</subject><subject>Biomarkers - blood</subject><subject>Case-Control Studies</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Inflammation - blood</subject><subject>Male</subject><subject>Psychiatry</subject><subject>Receptors, Urokinase Plasminogen Activator - blood</subject><subject>Schizophrenia</subject><subject>Schizophrenia - blood</subject><subject>Schizophrenia - pathology</subject><subject>Soluble urokinase-type plasminogen activator receptor</subject><issn>0165-1781</issn><issn>1872-7123</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2PFCEQhonRuOPoX9hw9NKzQH_QXIxmo67JJh5Wz4Rhqh1maWiBHh3jj7c6s-vBi0klUFS9VcVThFxytuGMd1eHzZRPdp8gbwT6G8bR-idkxXspKslF_ZSsMNBWXPb8grzI-cAYE1yp5-RCdFI2vFcr8vsO0jzSHP289UDnFO9dMBmqcpqATt7k0YX4DQI1trijKTHRBBam5eLhCD5TF-hoUDyZ4iCUTH-4ssf8uQCFn8ZC2mIkBhoHmu3e_YoTDh6ceUmeDcZnePVwrsnXD--_XN9Ut58_frp-d1vZRtSlAtXutjivQrfpZTNwBgofDH6mlbBTrW2UAFk3bd0bNrCa8aGTTNStkrI19Zq8PtedUvw-Qy56dNmC9yZAnLPmsmt43SvUr0l3TrUp5pxg0FNyo0knzZleyOuDfiSvF_KacbQehZcPPebtCLu_skfUmPD2nIDI4Ogg6WwRl4WdQ6BF76L7f483_5Sw3gVnjb-HE-RDnFNAjprrLDTTd8v-l_XzFomwTtR_AG-4r1w</recordid><startdate>20160228</startdate><enddate>20160228</enddate><creator>Genc, Abdullah</creator><creator>Kalelioglu, Tevfik</creator><creator>Karamustafalioglu, Nesrin</creator><creator>Tasdemir, Akif</creator><creator>Genc, Esra Sena</creator><creator>Akkus, Mustafa</creator><creator>Emul, Murat</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160228</creationdate><title>Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia</title><author>Genc, Abdullah ; Kalelioglu, Tevfik ; Karamustafalioglu, Nesrin ; Tasdemir, Akif ; Genc, Esra Sena ; Akkus, Mustafa ; Emul, Murat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-e95db7419c424874f10e9b74a19957ed95c492e734538a0f0301f6702359775a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Biomarkers - blood</topic><topic>Case-Control Studies</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Inflammation - blood</topic><topic>Male</topic><topic>Psychiatry</topic><topic>Receptors, Urokinase Plasminogen Activator - blood</topic><topic>Schizophrenia</topic><topic>Schizophrenia - blood</topic><topic>Schizophrenia - pathology</topic><topic>Soluble urokinase-type plasminogen activator receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Genc, Abdullah</creatorcontrib><creatorcontrib>Kalelioglu, Tevfik</creatorcontrib><creatorcontrib>Karamustafalioglu, Nesrin</creatorcontrib><creatorcontrib>Tasdemir, Akif</creatorcontrib><creatorcontrib>Genc, Esra Sena</creatorcontrib><creatorcontrib>Akkus, Mustafa</creatorcontrib><creatorcontrib>Emul, Murat</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Genc, Abdullah</au><au>Kalelioglu, Tevfik</au><au>Karamustafalioglu, Nesrin</au><au>Tasdemir, Akif</au><au>Genc, Esra Sena</au><au>Akkus, Mustafa</au><au>Emul, Murat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia</atitle><jtitle>Psychiatry research</jtitle><addtitle>Psychiatry Res</addtitle><date>2016-02-28</date><risdate>2016</risdate><volume>236</volume><spage>179</spage><epage>181</epage><pages>179-181</pages><issn>0165-1781</issn><eissn>1872-7123</eissn><abstract>Abstract Inflammatory abnormalities have been shown in the pathogenesis of schizophrenia. Soluble urokinase-type plasminogen activator receptor (suPAR) is a protein that is measurable in the circulating blood and reflects the inflammation in the body. We aimed to investigate serum suPAR levels in patients with schizophrenia who were in acute state and to compare with healthy controls. Forty five patients and 43 healthy controls were included in the study. We found no significant difference in suPAR levels between patients and controls, suggesting that suPAR as an inflammatory marker does not have a role in the inflammatory process of acute schizophrenia.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>26774189</pmid><doi>10.1016/j.psychres.2016.01.018</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-1781
ispartof Psychiatry research, 2016-02, Vol.236, p.179-181
issn 0165-1781
1872-7123
language eng
recordid cdi_proquest_miscellaneous_1764138945
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Biomarkers - blood
Case-Control Studies
Disease Progression
Humans
Inflammation
Inflammation - blood
Male
Psychiatry
Receptors, Urokinase Plasminogen Activator - blood
Schizophrenia
Schizophrenia - blood
Schizophrenia - pathology
Soluble urokinase-type plasminogen activator receptor
title Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T04%3A25%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20soluble%20urokinase-type%20plasminogen%20activator%20receptor%20levels%20in%20male%20patients%20with%20acute%20exacerbation%20of%20schizophrenia&rft.jtitle=Psychiatry%20research&rft.au=Genc,%20Abdullah&rft.date=2016-02-28&rft.volume=236&rft.spage=179&rft.epage=181&rft.pages=179-181&rft.issn=0165-1781&rft.eissn=1872-7123&rft_id=info:doi/10.1016/j.psychres.2016.01.018&rft_dat=%3Cproquest_cross%3E1764138945%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1764138945&rft_id=info:pmid/26774189&rft_els_id=1_s2_0_S0165178115301062&rfr_iscdi=true